Is it time to buy Cathie Wood’s beaten-up biotech companies (BATS:ARKG)?
Value Downunder
February 25, 2022
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed
The Cochlear Limited (ASX: COH) share price has bounced this
Australian investors had some respite on Friday, as volatility disappeared
Homegrown medical device company Resmed Inc (ASX: RMD) has updated
The S&P/ASX 200 (ASX:XJO) finished the week and the month
The Resmed CDI (ASX: RMD) share price has launched into
The S&P/ASX 200 (ASX:XJO) managed to push higher on Tuesday
The S&P/ASX 200 (ASX:XJO) suffered its worst day in months
The S&P/ASX 200 (ASX:XJO) overcame another 8% fall in the
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
